Renal Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
J Am Soc Nephrol. 2010 Oct;21(10):1657-66. doi: 10.1681/ASN.2009121253. Epub 2010 Jul 22.
Mutant forms of TRPC6 can activate NFAT-dependent transcription in vitro via calcium influx and activation of calcineurin. The same TRPC6 mutants can cause FSGS, but whether this involves an NFAT-dependent mechanism is unknown. Here, we generated mice that allow conditional induction of NFATc1. Mice with NFAT activation in nascent podocytes in utero developed proteinuria and glomerulosclerosis postnatally, resembling FSGS. NFAT activation in adult mice also caused progressive proteinuria and FSGS. Ultrastructural studies revealed podocyte foot process effacement and deposition of extracellular matrix. NFAT activation did not initially affect expression of podocin, synaptopodin, and nephrin but reduced their expression as glomerular injury progressed. In contrast, we observed upregulation of Wnt6 and Fzd9 in the mutant glomeruli before the onset of significant proteinuria, suggesting a potential role for Wnt signaling in the pathogenesis of NFAT-induced podocyte injury and FSGS. These results provide in vivo evidence for the involvement of NFAT signaling in podocytes, proteinuria, and glomerulosclerosis. Furthermore, this study suggests that NFAT activation may be a key intermediate step in the pathogenesis of mutant TRPC6-mediated FSGS and that suppression of NFAT activity may contribute to the antiproteinuric effects of calcineurin inhibitors.
突变型 TRPC6 可通过钙内流和钙调神经磷酸酶的激活,在体外激活 NFAT 依赖性转录。同样的 TRPC6 突变体可导致 FSGS,但这是否涉及 NFAT 依赖性机制尚不清楚。在这里,我们生成了允许条件性诱导 NFATc1 的小鼠。在胎儿期诱导 NFAT 在新生足细胞中激活的小鼠在出生后会发展为蛋白尿和肾小球硬化,类似于 FSGS。在成年小鼠中激活 NFAT 也会导致进行性蛋白尿和 FSGS。超微结构研究显示足细胞足突消失和细胞外基质沉积。NFAT 激活最初不会影响 podocin、synaptopodin 和 nephrin 的表达,但随着肾小球损伤的进展,它们的表达会减少。相比之下,我们在明显蛋白尿发生之前就观察到突变肾小球中 Wnt6 和 Fzd9 的上调,表明 Wnt 信号在 NFAT 诱导的足细胞损伤和 FSGS 的发病机制中可能发挥作用。这些结果为 NFAT 信号在足细胞、蛋白尿和肾小球硬化中的参与提供了体内证据。此外,本研究表明 NFAT 激活可能是突变型 TRPC6 介导的 FSGS 发病机制中的关键中间步骤,抑制 NFAT 活性可能有助于钙调神经磷酸酶抑制剂的抗蛋白尿作用。